跳至主要内容
临床试验/ISRCTN39669611
ISRCTN39669611已完成未知

Effect of polymorphic CYP2C19 genotype on the pharmacokinetics and pharmacodynamics of clopidogrel in healthy subjects

Korea University (South Korea)0 个研究点目标入组 24 人开始时间: 2007年9月17日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
24

研究概览

简要总结

2008 results in: https://www.ncbi.nlm.nih.gov/pubmed/18323861 (added 24/05/2019)

研究设计

研究类型
Interventional

入排标准

性别
Male

入选标准

  • 1. Healthy male subjects aged between 19 to 55
  • 2. Wish to participate in the study
  • 3. Informed consent for the trial

排除标准

  • 1. A history of or currently active clinically significant cardiac (including clinically significant abnormalities on Electrocardiogram [ECG] according to Principal Investigator [PI]), pulmonary, gastrointestinal, hepatic, renal, pancreatic, or neurological disease
  • 2. Heavy smoker and alcohol consumer
  • 3. Use of anticoagulants or medication within the last 1 month

研究者

发起方
Korea University (South Korea)

相似试验